EUVIMEDEUVIMED entdecken
Systematische Übersicht

Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice

Anastasia Farmaki iD, Evangelos Manolopoulos iD, Pantelis Natsiavas iD

OMICS: A Journal of Integrative Biology · 2024

DOI: 10.1089/omi.2024.0131 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift OMICS: A Journal of Integrative Biology, 2024. Verfasst von Anastasia Farmaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Precision Medicine, Decision Support Systems, Clinical, Pharmacogenetics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Digital health, an emerging scientific domain, attracts increasing attention as artificial intelligence and relevant software proliferate. Pharmacogenomics (PGx) is a core component of precision/personalized medicine driven by the overarching motto "the right drug, for the right patient, at the right dose, and the right time." PGx takes into consideration patients' genomic variations influencing drug efficacy and side effects. Despite its potentials for individually tailored therapeutics and improved clinical outcomes, adoption of PGx in clinical practice remains slow. We suggest that e-health tools such as clinical decision support systems (CDSSs) can help accelerate the PGx, precision/personalized medicine, and digital health emergence in everyday clinical practice worldwide. Herein, we present a systematic review that examines and maps the PGx-CDSSs used in clinical practice, including their salient features in both technical and clinical dimensions. Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines and research of the literature, 29 relevant journal articles were included in total, and 19 PGx-CDSSs were identified. In addition, we observed 10 technical components developed mostly as part of research initiatives, 7 of which could potentially facilitate future PGx-CDSSs implementation worldwide. Most of these initiatives are deployed in the United States, indicating a noticeable lack of, and the veritable need for, similar efforts globally, including Europe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineDecision Support Systems, ClinicalPharmacogeneticsHumansDigital Health

Stichwörter der Autor:innen

clinical decision support systemsdigital healthe-healthpersonalized medicinepharmacogenomicsprecision medicine

Autor:innen und Institutionen

  • Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
  • Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Alexandroupoli, Greece.

ORCID-Profile: Anastasia Farmaki, Evangelos Manolopoulos, Pantelis Natsiavas

Zitieren

APA

Farmaki, A., Manolopoulos, E., & Natsiavas, P. (2024). Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice. OMICS: A Journal of Integrative Biology. https://doi.org/10.1089/omi.2024.0131

Vancouver

Farmaki A, Manolopoulos E, Natsiavas P. Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice. OMICS: A Journal of Integrative Biology. 2024. doi:10.1089/omi.2024.0131

BibTeX
@article{Farmaki2024,
  author = {Farmaki, Anastasia and Manolopoulos, Evangelos and Natsiavas, Pantelis},
  title = {Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice},
  journal = {OMICS: A Journal of Integrative Biology},
  year = {2024},
  doi = {10.1089/omi.2024.0131}
}
Kostenlos starten →